American Medical Systems Inc. on Tuesday announced that it has sold its Her Option Global Endometrial Ablation product line to a Cooper Surgical for $20.5 million, according to the Minneapolis-St. Paul Business Journal. Cooper Surgical is a subsidiary of Pleasanton, Calif.-based Coopers Companies Inc., which develops, manufactures and markets health care products for the vision care and women’s health markets.
SurModics Inc., a pharmaceutical company based in Eden Prairie, is planning to terminate a licensing agreement with Ambrilia Biopharma Inc. in Canada. Ambrilia said it disagrees with SurModics contention that it’s not adequately developing Octreotide, a cancer drug. Ambrilia said it’s continuing to negotiate with SurModics but exploring legal options.
Mayo Clinic recently launched an initiative to reduce avoidable hospital readmissions, starting with three high-risk conditions: heart failure, heart attack and pneumonia, according to the Jacksonville Business Journal. The number of patients discharged and readmitted to a hospital within 30 days has become a red flag in health care, prompting a nationwide focus on eliminating unnecessary hospital readmissions.
Gov. Tim Pawlenty’s budget calls for the University of Minnesota to receive $100 million in bonding, half that amount devoted to a new physics and nanotechnology facility, according to Finance & Commerce in Minneapolis.
3M Cos of Maplewood has donated some of its royalty-bearing patents to the University of Minnesota’s law school and Office for Technology Commercialization, according to the Minneapolis-St. Paul Business Journal. The law school has established a 3M Fund for Law, Science and Technology to support various programs and initiatives in teaching and research. The OTC part of the University’s efforts to move research into the marketplace.